Buying the dip. If you’re looking to buy Charlotte’s Web shares, read this.
Company background
Colorado-based growers, the Stanley Brothers, developed Charlott’es Web in 2011. The strain gained popularity when it was used to treat a young girl named Charlotte, who suffered from severe and nearly continuous epileptic seizures (300 seizures a week).
The high CBD strain of marijuana was able to successfully reduce her seizures to only a hand full a month.
Charlotte’s Web Shares
Charlottes Web has recently had a big sell-off. All Cannabis stocks are down on the very poor results and losses published by Canopy Growth.
Until recently, Canada had only allowed the sale of weed, oils and gels. That has now changed and Canada has paved the way for legal edible products, vapes and cannabis drinks. These products will hit the shelves around Christmas and should generate a buzz around the investor community.
So perhaps the stocks will bounce from their current levels and shares like Charlotte’s Web which is CBD based will bounce off their current lows. CW has a steady growth in sales.
Canopy Growth recently purchases a 72% stake in Biosteel Sports Nutrition. This will allow Canopy Growth to be nicely positioned ahead of CBD being permitted across all major sports. This should also play into the hands of leading CBD brands like Charlottes’ Web and zootlycare.
Charlotte’s Web: What the company is up to
Charlottes Web E-commerce comprised 55% of sales for the fiscal year 2018. The brand sold through over 6,000 retail locations. They are also in active discussions with national retail and distribution accounts.
The brand is targeting the expansion of distribution channels, including national grocery, drug, mass market, pet and natural/specialty retailers. Finally, 4 national retail chains (grocery, drugstore) carry their products.
